eLife is a non-profit organisation inspired by research funders and led by scientists. Our mission is to help scientists accelerate discovery by operating a platform for research communication that ...

The Biostatistics, Bioinformatics and Epidemiology Program (BBE) supplies the statistical and mathematical modeling expertise needed within Fred Hutch’s Vaccine and Infectious Disease Division to ...

Peritoneal metastasis/recurrence results in poor prognosis and failure of radical resection in cholangiocarcinoma (CCA) patients, but the molecular mechanisms and potential therapy strategies remain ...

Cholangiocarcinoma (CCA) is a rare and aggressive solid tumor originating from cholangiocytes lining the biliary ducts. It is the second most common primary hepatic malignancy, with an increasing ...

Colorectal adenocarcinoma incidence is decreasing overall but increasing among individuals aged 15 to 34 years, with an APC of 1.75. Pancreatic adenocarcinoma incidence is rising across all age ...

Stage at diagnosis was categorized using the Surveillance, Epidemiology, and End Results Program (SEER) summary staging system and grouped into early or late stages. Patients were also categorized ...

In addition, those with known fibrolamellar HCC, sarcomatoid HCC, or mixed cholangiocarcinoma and HCC, were also not eligible for participation. The primary end point of the study was OS, and ...

Liver cancer is the fourth leading cause of cancer-related deaths worldwide. According to estimates by the World Health Organization, more than one million people are expected to die from this disease ...

A specific marker for ICC is currently not available; the diagnosis is established by exclusion of metastatic carcinoma and HCC. This is first achieved by the knowledge of the clinical history and ...

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...